PNO: Catheter, Percutaneous, Cutting/Scoring
What it covers
To reduce vascular stenosis by dilatation and apposition of the cutting/scoring surfaces to the stenotic material
FDA’s definition of product code PNO, from the Product Classification database.
Recent clearances
| 510(k) | Device | Applicant | Decision | Type |
|---|---|---|---|---|
| K261778 | JADE SCORE PTA Scoring Balloon Dilatation Catheter | OrbusNeich Medical (Shenzhen) Co., Ltd. | Sep 16, 2026 | Traditional |
| K260012 | UltraScore Focused Force PTA Balloon | Bard Peripheral Vascular, Inc. | Feb 4, 2026 | Special |
| K243944 | Aperta NSE PTA Balloon Dilatation Catheter | Goodman Co., Ltd. | Apr 22, 2025 | Traditional |
| K242254 | D·Kutting LL Peripheral Scoring Balloon Dilatation Catheter | Dk Medical Technology Co., Ltd. | Apr 21, 2025 | Traditional |
| K241478 | Tri-Wedge PTA Scoring Balloon Dilatation Catheter | Brosmed Medical Co., Ltd. | Oct 22, 2024 | Traditional |
| K232258 | XO Constrain Percutaneous Transluminal Angioplasty Constraining Catheter | Transit Scientific, LLC | Jun 17, 2024 | Traditional |
| K232013 | Aperta NSE PTA Balloon Dilatation Catheter (AW18-05040040/AA18-05040040, AW18-09040040/AA18-09040040, AW18-14540040, AW18-05050040/AA18-05050040, AW18-09050040/AA18-09050040, AW18-14550040, AW18-05060040/AA18-05060040, AW18-09060040/AA18-09060040, AW18-14560040 AW18-05070040/AA18-05070040, AW18-09070040/AA18-09070040, AW18-14570040, AW18-05080040/AA18-05080040, AW18-09080040/AA18-09080040, AW18-14580040) | Goodman Co., Ltd. | Mar 28, 2024 | Traditional |
| K232207 | D·Kutting PTA Scoring Balloon Dilatation Catheter | Dk Medical Technology Co., Ltd. | Mar 7, 2024 | Traditional |
| K221986 | XO Score LP Percutaneous Transluminal Angioplasty Scoring Catheter, XO Score LP Catheter | Transit Scientific, LLC | Oct 18, 2022 | Special |
| K220704 | Serranator PTA Serration Balloon Catheter | Cagent Vascular, LLC | May 4, 2022 | Traditional |
Clearances by year
29 PNO 510(k)s were cleared from 2011 to Oct 29, 2026. Days to decision run from the day FDA received the 510(k) to its decision, including time on hold.
| Year | Clearances | Median days to decision |
|---|---|---|
| 2026 (so far) | 2 | 70 |
| 2025 | 2 | 194 |
| 2024 | 4 | 246 |
| 2022 | 2 | 80 |
| 2021 | 1 | 19 |
| 2020 | 4 | 94 |
| 2019 | 1 | 257 |
| 2017 | 3 | 74 |
| 2016 | 1 | 243 |
| 2015 | 4 | 84 |
| 2014 | 1 | 113 |
| 2013 | 1 | 133 |
| 2012 | 1 | 216 |
| 2011 | 2 | 29 |
Who submits
17 applicants cleared a PNO device since 2011. 76% of the clearances went to applicants in United States, then China (14%), Japan (7%) and Ireland (3%). By type: Traditional 66% and Special 34%.
| Applicant | Clearances since 2011 |
|---|---|
| Angioscore, Inc. | 5 |
| Cagent Vascular, LLC | 5 |
| Bard Peripheral Vascular, Inc. | 2 |
| Dk Medical Technology Co., Ltd. | 2 |
| Goodman Co., Ltd. | 2 |
| Transit Scientific, LLC | 2 |
| Boston Scientific Limited | 1 |
| Brosmed Medical Co., Ltd. | 1 |
How FDA classifies it
Class II (performance standards).
From 21 CFR 870.1250.
Standards
21 CFR 870.1250 names no consensus standards. Check FDA’s recognized standards database, or ask which standards recent PNO clearances declared.
Ask about PNO
Questions about PNO
What is FDA product code PNO?
Product code PNO, “Catheter, Percutaneous, Cutting/Scoring” in FDA's classification database, is a Class II device type under 21 CFR 870.1250 (percutaneous catheter), reviewed by FDA's Cardiovascular panel. FDA's 510(k) database lists 46 clearances under PNO, 29 of them since 2011.
How many 510(k) clearances are there under PNO?
FDA’s 510(k) database listed 46 clearances under PNO as of Oct 29, 2026, 29 of them decided since 2011; the most recent decision was Sep 16, 2026. The Predicate Finder searches the live database.
How long does FDA take to clear a PNO 510(k)?
For the 4 PNO clearances decided in the two years before Oct 29, 2026, the median time from FDA receiving the 510(k) to its decision was 117 days. That counts calendar days, including time the submission was on hold waiting for answers from the submitter.
Which companies have the most PNO clearances?
Since 2011: Angioscore, Inc. (5), Cagent Vascular, LLC (5), Bard Peripheral Vascular, Inc. (2), Dk Medical Technology Co., Ltd. (2) and Goodman Co., Ltd. (2). 17 applicants have cleared a PNO device in that time.